(Q42558993)

2 November 2017

Optimal meropenem concentrations to treat multidrug-resistant Pseudomonas aeruginosa septic shock (English)

1 reference

2 November 2017

multiple drug resistance

1 reference

1 reference

1 reference

Pseudomonas aeruginosa

object named as

Pseudomonas aeruginosa

1 reference

4

Jean-Louis Vincent

1 reference

2 November 2017

Fabio Silvio Taccone

1

1 reference

2 November 2017

Frédéric Cotton

series ordinal

2

1 reference

2 November 2017

Sandrine Roisin

series ordinal

3

1 reference

2 November 2017

Frédérique Jacobs

series ordinal

5

1 reference

2 November 2017

language of work or name

English

0 references

publication date

30 January 2012

1 reference

2 November 2017

3

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

2 November 2017

56

1 reference

2 November 2017

4

1 reference

2 November 2017

2129-2131

1 reference

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

2 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318384

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318384

Multidrug-resistant Gram-negative bacteria: how to treat and for how long

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318384

Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318384

Prospective monitoring of cefepime in intensive care unit adult patients

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318384

Effect of obesity on the pharmacokinetics of drugs in humans

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318384

A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318384

Pharmacokinetic issues for antibiotics in the critically ill patient

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318384

Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318384

Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC beta-lactamase: implications for antibiotic use.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318384

Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318384

Comparison of the pharmacodynamics of meropenem in patients with ventilator-associated pneumonia following administration by 3-hour infusion or bolus injection.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318384

In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318384

Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318384

Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3318384

Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22290984

12 December 2020

inferred from PubMed ID database lookup

Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22290984

12 December 2020

inferred from PubMed ID database lookup

Implications of augmented renal clearance in critically ill patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22290984

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1128/AAC.06389-11

1 reference

2 November 2017

1 reference

2 November 2017

PubMed publication ID

22290984

1 reference